Reed Vaughn Tuckson Cti Biopharma Corp (CTIC) insider trading activity

Reed Vaughn Tuckson is Director of CTI BIOPHARMA CORP. Currently has a direct ownership of 0 shares of CTIC, which is worth approximately $0. The most recent transaction as insider was on Jun 26, 2023, when has been sold 48,639 shares (Common Stock) at a price of $9.1 per share, resulting in proceeds of $442,614. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Reed Vaughn Tuckson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 26 2023	SELL Disposition due to a tender of shares in a change of control transaction	$442,614 $9.1 p/Share	48,639 Reduced 100.0%	0 Common Stock

Also insider at

HSIC

HENRY SCHEIN INC Healthcare

ADVM

Adverum Biotechnologies, Inc. Healthcare

RVT